Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Frozen MMRV (ProQuad) Given Concomitantly vs Nonconcomitantly
NCT00984295Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2000
- Primary completion
- Oct 2001
- Modality
- Live Attenuated Vaccines
01
Overview
A Phase 3 trial of varicella virus vaccine live in measles, mumps, rubella, varicella (VZV), sponsored by Merck & Co.. Started Jun 2000; status: completed.
02
Drugs
varicella virus vaccine live
03
Conditions
measlesmumpsrubellavaricella (VZV)
Beyond the preview
Go deeper on NCT00984295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00984295.